From: Sexual dimorphism in myocardial acylcarnitine and triglyceride metabolism
 | Male | Female | ANOVA | ||||
---|---|---|---|---|---|---|---|
 | Wistar | GK | Wistar | GK | Phenotype | Sex | Phen × sex |
(N = 4) | (N = 4) | (N = 4) | (N = 4) |  |  |  | |
Weight (g) | 491.67 ± 5.34 | 334.17 ± 10.26* | 256.97 ± 5.35 | 230 ± 2.80‡ | <0.001 | <0.001 | <0.001 |
Insulin (μU/mL) | 14.5 ± 5.76 | 12.33 ± 2.00 | 11.86 ± 3.56 | 7.46 1.37 | 0.199 | 0.348 | 0.362 |
Glucose (mmol/L) | 7.80 ± 0.43 | 9.85 ± 0.54†| 7.68 ± 0.57 | 9.76 ± 1.25†| 0.020 | .0936 | 0.745 |
Serum NEFA (μmol/L) | 1084.50 ± 155.94 | 1434.25 ± 124.64 | 1421.75 ± 202.11 | 1406.25 ± 130.01 | 0.305 | 0.341 | 0.265 |
Serum TG (μmol/L) | 877.01 ± 155.69 | 1219.97 ± 119.37‡ | 525.78 ± 88.95 | 1157.80 ± 244.44‡ | 0.011 | 0.228 | 0.392 |
Tissue NEFA (μg/mg) | 0.77 ± 0.03 | 1.34 ± 0.18†| 0.74 ± 0.04 | 0.98 ± 0.06 | 0.0005 | 0.071 | 1 |